Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,704,427
-$198,804 QoQ
Shares Held
1,061,441
-21.7% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SANA ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,704,427 | 1,061,441 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,903,231 | 1,355,289 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,814,638 | 1,182,958 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,126,149 | 1,443,986 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,127,036 | 1,145,435 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,224,420 | 728,822 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $731,630 | 448,853 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,267,709 | 304,738 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,313,883 | 240,638 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,737,270 | 373,727 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,254,273 | 307,420 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $419,275 | 108,340 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $878,443 | 147,390 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $533,148 | 163,043 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,350,400 | 341,874 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $358,998 | 59,833 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,459,603 | 226,999 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,542,518 | 307,811 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,717,768 | 110,967 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,238,712 | 55,005 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $169,823 | 8,638 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $152,355 | 4,552 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||